It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Patients undergoing Magnetic Resonance Imaging (MRI) often experience anxiety and sometimes distress prior to and during scanning. Here a full MRI compatible virtual reality (VR) system is described and tested with the aim of creating a radically different experience. Potential benefits could accrue from the strong sense of immersion that can be created with VR, which could create sense experiences designed to avoid the perception of being enclosed and could also provide new modes of diversion and interaction that could make even lengthy MRI examinations much less challenging. Most current VR systems rely on head mounted displays combined with head motion tracking to achieve and maintain a visceral sense of a tangible virtual world, but this technology and approach encourages physical motion, which would be unacceptable and could be physically incompatible for MRI. The proposed VR system uses gaze tracking to control and interact with a virtual world. MRI compatible cameras are used to allow real time eye tracking and robust gaze tracking is achieved through an adaptive calibration strategy in which each successive VR interaction initiated by the subject updates the gaze estimation model. A dedicated VR framework has been developed including a rich virtual world and gaze-controlled game content. To aid in achieving immersive experiences physical sensations, including noise, vibration and proprioception associated with patient table movements, have been made congruent with the presented virtual scene. A live video link allows subject-carer interaction, projecting a supportive presence into the virtual world.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 King’s College London, Centre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
2 King’s College London, Centre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764); Imperial College London, Department of Bioengineering, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
3 Chalmers University of Technology, Department of Electrical Engineering, Gothenburg, Sweden (GRID:grid.5371.0) (ISNI:0000 0001 0775 6028)
4 Imperial College London, Department of Bioengineering, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
5 Brunel University London, Department of Mechanical and Aerospace Engineering, London, UK (GRID:grid.7728.a) (ISNI:0000 0001 0724 6933)
6 Imperial College London, Department of Physics, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)